RxDoctor Payments Data

Kelly Kim, MD

Clinical Cardiac Electrophysiology · Wheat Ridge, CONPI 1356309009

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,008 of the $4,609 with a category attached, or 65.3%. Medtronic accounts for 98.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $4,543 and has fallen 99.4% since, to $27 in 2024. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CO, where the typical reported total is $11,587.

$4,609in general payments, 2019–2025

Across 44 payments — averaging $104.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Cordis US CORP.$27
  • Pfizer$26
  • Boston Scientific$24
  • Amgen$15

What the payments were for

  • Travel & lodging$3,00865%
  • Food & beverage$1,60035%

General payments by program year

19
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic40$4,517
Cordis US CORP.1$27
Pfizer1$26
Boston Scientific1$24
Amgen1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,609 in reported general payments places this provider in the 25th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$183,512
Medicare patients
859
Services billed
3,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban723$969,619
XareltoRivaroxaban159$222,637
EntrestoSacubitril/Valsartan61$90,259
JardianceEmpagliflozin27$29,627
Repatha SureclickEvolocumab31$17,103
Metoprolol Succinate785$9,584
Propafenone Hcl ErPropafenone Hcl34$9,197
Diltiazem 24hr Er (Cd)Diltiazem Hcl199$6,981
Flecainide Acetate80$4,974
Atorvastatin Calcium362$3,210
Dabigatran EtexilateDabigatran Etexilate Mesylate12$2,271
Lisinopril222$1,706
Losartan Potassium199$1,697
Digoxin47$1,694
Metoprolol Tartrate174$1,448

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$969,619723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

Other clinical cardiac electrophysiology in Wheat Ridge

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →